Moon Du Geon
Department of Urology, Korea University College of Medicine, Seoul, Korea.
Transl Androl Urol. 2016 Aug;5(4):502-7. doi: 10.21037/tau.2016.05.06.
Management of premature ejaculation (PE) has evolved tremandoulsy over the last 20 years. Selective serotonin reuptake inhibitor (SSRI) antidepressants and local anesthetics are the most and best studied treatments. This evidence has led to the establishment of an evidence-based definition of PE and the International Society for Sexual Medicine (ISSM) guidelines for the diagnosis and treatment of PE. The current treatment of choice for PE according to the ISSM guidelines is a centrally acting SSRI or peripherally acting topical anesthetics. Despite the progress in threating PE, the drawbacks of these medical treatments are controversial. Before the ISSM guidelines were established, selective dorsal neurectomy (SDN) and glans penis augmentation (GPA) using a hyaluronic acid (HA) gel were developed to decrease sensitivity of the glans penis but later ISSM guidelines do not recommend surgical treatment because of possible permanent loss of sexual function and insufficient reliable data. Despite the drawbacks of medical treatments and debates about the ISSM guideline, surgical treatment for PE has increased continuously in Asian countries for non-responders to medical treatment. In contrast to the concerns outlined in the ISSM guidelines, SDN has been reported as effective and safe with rare sensory loss. Percutaneous computed tomography-guided cryoablation of the dorsal penile nerve and neuromodulation of the dorsal penile nerve by pulsed radiofrequency are reported as effective and safe for PE. It is time to re-evaluate rather than ignore surgical treatments for PE because doctors and patients need surgical alternatives for patients with PE who are not satisfied with medical treatment. SDN has a definite role in the efficacy but needs more safety data to be used as standard surgical treatment for PE. SDN must be performed carefully and more well-designed studies are needed. GPA with a HA gel does not induce serious sensory loss in patients with ED erectile dysfunction and the recommendation should be re-evaluated by the ISSM after additional reliable studies are performed.
早泄(PE)的治疗在过去20年中发生了巨大演变。选择性5-羟色胺再摄取抑制剂(SSRI)类抗抑郁药和局部麻醉剂是研究最多且最佳的治疗方法。这些证据促使了基于证据的早泄定义的确立以及国际性医学学会(ISSM)早泄诊断和治疗指南的制定。根据ISSM指南,目前早泄的首选治疗方法是中枢作用的SSRI或外周作用的局部麻醉剂。尽管在治疗早泄方面取得了进展,但这些药物治疗的缺点仍存在争议。在ISSM指南制定之前,曾开展选择性背神经切除术(SDN)和使用透明质酸(HA)凝胶进行阴茎头增大术(GPA)以降低阴茎头的敏感性,但后来ISSM指南不推荐手术治疗,因为可能导致永久性性功能丧失且可靠数据不足。尽管药物治疗存在缺点且围绕ISSM指南存在争议,但在亚洲国家,针对药物治疗无反应者,早泄的手术治疗仍在持续增加。与ISSM指南中所述的担忧不同,有报道称SDN有效且安全,感觉丧失罕见。经皮计算机断层扫描引导下阴茎背神经冷冻消融术以及脉冲射频对阴茎背神经的神经调节术据报道对早泄有效且安全。现在是重新评估而非忽视早泄手术治疗的时候了,因为医生和患者都需要为对药物治疗不满意的早泄患者提供手术替代方案。SDN在疗效方面有明确作用,但需要更多安全数据才能作为早泄的标准手术治疗方法。必须谨慎进行SDN,且需要开展更多设计良好的研究。使用HA凝胶的GPA在勃起功能障碍(ED)患者中不会导致严重感觉丧失,在进行更多可靠研究后,ISSM应重新评估这一推荐。